Ann: December 2023 Preclinical & Clinical Program Update, page-53

I'm going to be blunt with you.
2023 from an outside perspective screamed of highschool lord of the flies, powerplay bull@#$%.

Somewhere in my history 12-14months ago i said i was waiting for the turning point of RC220, I.V. as that would be a major turning point for me. That, RAC has delivered and yet rather than being excited, here I am absolutely writing off my investment here.

We were promised trial sites open in Europe at the time and got crickets.
The Au trial was a major flop.
This was with RC110, yes, its good we didnt waste the time and money. But that "good" comes from incompetence in actually getting trials up and running and people dosed.

Honestly, I would have rather we dosed people and have trials done and demonstrated competence and then need to run more trials woth RC220. I would happily pony up more cash. I suspect many others also would have.

As it stands now, we have unintentionally drifted around a corner after losing control because of absolute ##%ery at the wheel, we pulled it off and said "how cool was it that we didnt crash?"

I don't expect you to pull off anything and looking at market sentiment and rate of option conversion... nor does anybody else.